Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Spillane

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Plastic and Reconstructive Surgery|September 28, 2016
Reducing Decisional Conflict and Enhancing Satisfaction with Information among Women Considering Breast Reconstruction following Mastectomy: Results from the BRECONDA Randomized Controlled TrialKerry A Sherman, Laura-Kate E Shaw, Caleb J Winch, et al.
The Medical Journal of Australia|September 24, 2025
Changes in patient management after preoperative MRI for newly diagnosed breast cancer: a multicentre prospective observational studyMichael L Marinovich, Nehmat Houssami, Andrew Spillane, et al.
Annals of Surgical Oncology|December 3, 2022
Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with MelanomaTrine Schoenfeldt, John F Thompson, Serigne Lo, et al.
ANZ Journal of Surgery|November 27, 2019
Window of opportunity treatment in breast cancerJulia Chen, Neshanth Easwaralingam, Sanjay Warrier, et al.
Annals of Surgical Oncology|June 30, 2022
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma MetastasesAnna K Lawless, David J Coker, Serigne N Lo, et al.
BMJ Open|January 5, 2023
Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot studyKathy Dempsey, Robyn Saw, Iris Bartula, et al.
Psycho-Oncology|December 18, 2024
Patient and Staff Experiences of Embedding Electronic Patient Reported Outcome Measures for Distress Screening and Quality of Life Assessment, Into Routine Melanoma Care: A Mixed-Methods StudyKathy Dempsey, Robyn Saw, Iris Bartula, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2025
Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trialMichael Russell, Louise Emmett, Barbara Peric, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2022
Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patientsMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2022
Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomesMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Plastic and Reconstructive Surgery|September 28, 2016
Reducing Decisional Conflict and Enhancing Satisfaction with Information among Women Considering Breast Reconstruction following Mastectomy: Results from the BRECONDA Randomized Controlled TrialKerry A Sherman, Laura-Kate E Shaw, Caleb J Winch, et al.
The Medical Journal of Australia|September 24, 2025
Changes in patient management after preoperative MRI for newly diagnosed breast cancer: a multicentre prospective observational studyMichael L Marinovich, Nehmat Houssami, Andrew Spillane, et al.
Annals of Surgical Oncology|December 3, 2022
Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with MelanomaTrine Schoenfeldt, John F Thompson, Serigne Lo, et al.
ANZ Journal of Surgery|November 27, 2019
Window of opportunity treatment in breast cancerJulia Chen, Neshanth Easwaralingam, Sanjay Warrier, et al.
Annals of Surgical Oncology|June 30, 2022
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma MetastasesAnna K Lawless, David J Coker, Serigne N Lo, et al.
BMJ Open|January 5, 2023
Embedding electronic patient-reported outcome measures into routine care for patients with stage III MELanoma (ePROMs-MEL): protocol for a prospective, longitudinal, mixed-methods pilot studyKathy Dempsey, Robyn Saw, Iris Bartula, et al.
Psycho-Oncology|December 18, 2024
Patient and Staff Experiences of Embedding Electronic Patient Reported Outcome Measures for Distress Screening and Quality of Life Assessment, Into Routine Melanoma Care: A Mixed-Methods StudyKathy Dempsey, Robyn Saw, Iris Bartula, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2025
Accuracy of PET/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trialMichael Russell, Louise Emmett, Barbara Peric, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2022
Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patientsMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2022
Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomesMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
Pageof 7